123 related articles for article (PubMed ID: 37827263)
1. Lesion area reduction and the amelioration of anxiety and depression states in psoriasis patients: A prospective clinical study.
Yu Y; Zhou J; Huang D; Zhong X; Kong L; Ding Y; Bi X; Deng H; Chen J; Gu J; Lu J; Shi Y
J Affect Disord; 2024 Jan; 344():335-338. PubMed ID: 37827263
[TBL] [Abstract][Full Text] [Related]
2. Mental health self-assessment in patients with moderate to severe psoriasis: an observational, multicenter study of 1164 patients in Spain (the VACAP Study).
Pujol RM; Puig L; Daudén E; Sánchez-Carazo JL; Toribio J; Vanaclocha F; Yébenes M; Sabater E; Casado MA; Caloto MT; Aragón B
Actas Dermosifiliogr; 2013 Dec; 104(10):897-903. PubMed ID: 24112536
[TBL] [Abstract][Full Text] [Related]
3. Anxiety and depression in patients with moderate-to-severe psoriasis and comparison of change from baseline after treatment with guselkumab vs. adalimumab: results from the Phase 3 VOYAGE 2 study.
Gordon KB; Armstrong AW; Han C; Foley P; Song M; Wasfi Y; You Y; Shen YK; Reich K
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1940-1949. PubMed ID: 29706008
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial stress affects the change of mental distress under dermatological treatment-A prospective cohort study in patients with psoriasis.
Wintermann GB; Bierling AL; Peters EMJ; Abraham S; Beissert S; Weidner K
Stress Health; 2024 Feb; 40(1):e3263. PubMed ID: 37243509
[TBL] [Abstract][Full Text] [Related]
5. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
Park KK; Wu JJ; Koo J
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis.
Bagel J
J Drugs Dermatol; 2011 Apr; 10(4):366-71. PubMed ID: 21455546
[TBL] [Abstract][Full Text] [Related]
7. Depression Symptoms Predict Worse Clinical Response to Etanercept Treatment in Psoriasis Patients.
Jin W; Zhang S; Duan Y
Dermatology; 2019; 235(1):55-64. PubMed ID: 30408786
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis.
Rui W; Xiangyu D; Fang X; Long G; Yi Y; Wenjuan W; Tian H; Xiaoning Z; Yong Z; Jianfeng F; Hengjin L; Chengxin L
Medicine (Baltimore); 2017 Dec; 96(50):e8677. PubMed ID: 29390261
[TBL] [Abstract][Full Text] [Related]
9. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
[TBL] [Abstract][Full Text] [Related]
10. Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.
Talamonti M; Malara G; Natalini Y; Bardazzi F; Conti A; Chiricozzi A; Mugheddu C; Gisondi P; Piaserico S; Pagnanelli G; Amerio P; Potenza C; Cantoresi F; Fargnoli MC; Balato A; Loconsole F; Offidani A; Bonifati C; Prignano F; Bartezaghi M; Rausa A; Aloisi E; Orsenigo R; Costanzo A;
Acta Derm Venereol; 2021 Mar; 101(3):adv00422. PubMed ID: 33269404
[TBL] [Abstract][Full Text] [Related]
11. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
Ortonne JP; Khemis A; Koo JY; Choi J
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):556-63. PubMed ID: 16164708
[TBL] [Abstract][Full Text] [Related]
12. Etanercept reduces anxiety and depression in psoriasis patients, and sustained depression correlates with reduced therapeutic response to etanercept.
Yang A; Xin X; Yang W; Li M; Yang W; Li L; Liu X
Ann Dermatol Venereol; 2019 May; 146(5):363-371. PubMed ID: 31047699
[TBL] [Abstract][Full Text] [Related]
13. Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients.
Bruins FM; Bronckers IMGJ; Groenewoud HMM; van de Kerkhof PCM; de Jong EMGJ; Seyger MMB
JAMA Dermatol; 2020 Jan; 156(1):72-78. PubMed ID: 31774449
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial.
Lynch M; Malara A; Timoney I; Vencken S; Ahern T; Awdeh F; Sweeney C; Galligan M; Kelly G; Hughes R; Murad A; Hambly R; O'Shea D; Doran P; Kirby B
Dermatology; 2022; 238(1):140-147. PubMed ID: 33866313
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients.
Tabra SA; Abd Elghany SE; Amer RA; Fouda MH; Abu-Zaid MH
Clin Rheumatol; 2022 Nov; 41(11):3391-3399. PubMed ID: 35861930
[TBL] [Abstract][Full Text] [Related]
17. Impact of an eHealth Smartphone App on the Mental Health of Patients With Psoriasis: Prospective Randomized Controlled Intervention Study.
Domogalla L; Beck A; Schulze-Hagen T; Herr R; Benecke J; Schmieder A
JMIR Mhealth Uhealth; 2021 Oct; 9(10):e28149. PubMed ID: 34431478
[TBL] [Abstract][Full Text] [Related]
18. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
Gambichler T; Tigges C; Scola N; Weber J; Skrygan M; Bechara FG; Altmeyer P; Kreuter A
Br J Dermatol; 2011 Jun; 164(6):1383-6. PubMed ID: 21466532
[TBL] [Abstract][Full Text] [Related]
19. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
Jacobson CC; Kimball AB
Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
[TBL] [Abstract][Full Text] [Related]
20. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
Tzaneva S; Geroldinger A; Trattner H; Tanew A
Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
